182 related articles for article (PubMed ID: 17722472)
1. [Angiogenesis in bone marrow of myelodysplastic syndrome patients].
Madry K; Dwilewicz-Trojaczek J; Suleiman W; Paszkowska-Kowalewska M; Ziarkiewicz-Wróblewska B
Pol Arch Med Wewn; 2007 Apr; 117(4):25-30. PubMed ID: 17722472
[TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical detection of vascular endothelial growth factor (VEGF) in the bone marrow in patients with myelodysplastic syndromes: correlation between VEGF expression and the FAB category.
Wimazal F; Krauth MT; Vales A; Böhm A; Agis H; Sonneck K; Aichberger KJ; Mayerhofer M; Simonitsch-Klupp I; Müllauer L; Sperr WR; Valent P
Leuk Lymphoma; 2006 Mar; 47(3):451-60. PubMed ID: 16396768
[TBL] [Abstract][Full Text] [Related]
3. Angiogenesis in relation to clinical stage, apoptosis and prognostic score in myelodysplastic syndromes.
Lundberg LG; Hellström-Lindberg E; Kanter-Lewensohn L; Lerner R; Palmblad J
Leuk Res; 2006 Mar; 30(3):247-53. PubMed ID: 16099505
[TBL] [Abstract][Full Text] [Related]
4. [A preliminary observation of bone marrow angiogenesis in patients with myelodysplastic syndromes].
Zou WR; Liu T; Meng WT; Yu J; Niu T
Sichuan Da Xue Xue Bao Yi Xue Ban; 2005 Jan; 36(1):69-71. PubMed ID: 15702784
[TBL] [Abstract][Full Text] [Related]
5. Serum evaluation of angiogenic cytokine basic fibroblast growth factor, hepatocyte growth factor and TNF-alpha in patients with myelodysplastic syndromes: correlation with bone marrow microvascular density.
Alexandrakis MG; Passam FH; Pappa CA; Damilakis J; Tsirakis G; Kandidaki E; Passam AM; Stathopoulos EN; Kyriakou DS
Int J Immunopathol Pharmacol; 2005; 18(2):287-95. PubMed ID: 15888251
[TBL] [Abstract][Full Text] [Related]
6. Angiogenesis in myelodysplastic syndromes.
Pruneri G; Bertolini F; Soligo D; Carboni N; Cortelezzi A; Ferrucci PF; Buffa R; Lambertenghi-Deliliers G; Pezzella F
Br J Cancer; 1999 Dec; 81(8):1398-401. PubMed ID: 10604739
[TBL] [Abstract][Full Text] [Related]
7. Increased angiogenesis in the bone marrow of HIV-positive patients with myelodysplasia.
Patsouris E; Korkolopoulou P; Androulaki A; Douzinas E; Kosmopoulou O; Kordossis T
Pathology; 2003 Aug; 35(4):330-5. PubMed ID: 12959769
[TBL] [Abstract][Full Text] [Related]
8. Over-expression of tumor necrosis factor-alpha in bone marrow biopsies from patients with myelodysplastic syndromes: relationship to anemia and prognosis.
Stifter G; Heiss S; Gastl G; Tzankov A; Stauder R
Eur J Haematol; 2005 Dec; 75(6):485-91. PubMed ID: 16313260
[TBL] [Abstract][Full Text] [Related]
9. Biomarkers of angiogenesis as prognostic factors in myelodysplastic syndrome patients treated with hypomethylating agents.
Kim CK; Han DH; Ji YS; Lee MS; Min CW; Park SK; Kim SH; Yun J; Kim HJ; Kim KH; Lee KT; Won JH; Hong DS; Kim HK
Leuk Res; 2016 Nov; 50():21-28. PubMed ID: 27639703
[TBL] [Abstract][Full Text] [Related]
10. Prognostic evaluation of the microvascular network in myelodysplastic syndromes.
Korkolopoulou P; Apostolidou E; Pavlopoulos PM; Kavantzas N; Vyniou N; Thymara I; Terpos E; Patsouris E; Yataganas X; Davaris P
Leukemia; 2001 Sep; 15(9):1369-76. PubMed ID: 11516097
[TBL] [Abstract][Full Text] [Related]
11. Angiogenesis and survival in patients with myelodysplastic syndrome.
Savic A; Cemerikic-Martinovic V; Dovat S; Rajic N; Urosevic I; Sekulic B; Kvrgic V; Popovic S
Pathol Oncol Res; 2012 Jul; 18(3):681-90. PubMed ID: 22270865
[TBL] [Abstract][Full Text] [Related]
12. Correlation of bone marrow angiogenesis and mast cells with tryptase activity in myelodysplastic syndromes.
Ribatti D; Polimeno G; Vacca A; Marzullo A; Crivellato E; Nico B; Lucarelli G; Dammacco F
Leukemia; 2002 Sep; 16(9):1680-4. PubMed ID: 12200681
[TBL] [Abstract][Full Text] [Related]
13. [Expression of Fas, FasL and Bcl-2 and apoptosis of bone marrow CD34+ cells in patients with myelodysplastic syndrome].
Zhang Z; Xie J
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2003 Jun; 11(3):274-7. PubMed ID: 12844412
[TBL] [Abstract][Full Text] [Related]
14. Increased microvascular network in bone marrow of HIV-positive haemophilic patients.
Patsouris E; Katsarou O; Korkolopoulou P; Kotsi P; Kouramba A; Androulaki A; Karafoulidou A
HIV Med; 2004 Jan; 5(1):18-25. PubMed ID: 14731165
[TBL] [Abstract][Full Text] [Related]
15. Expression of the proliferation-associated nuclear protein MIB-1 and its relationship with microvascular density in bone marrow biopsies of patients with myelodysplastic syndromes.
Alexandrakis MG; Passam FH; Kyriakou DS; Dambaki C; Katrinakis G; Tsirakis G; Konsolas J; Stathopoulos EN
J Mol Histol; 2004 Nov; 35(8-9):857-63. PubMed ID: 15609099
[TBL] [Abstract][Full Text] [Related]
16. Regulation of angiogenesis in the bone marrow of myelodysplastic syndromes transforming to overt leukaemia.
Keith T; Araki Y; Ohyagi M; Hasegawa M; Yamamoto K; Kurata M; Nakagawa Y; Suzuki K; Kitagawa M
Br J Haematol; 2007 May; 137(3):206-15. PubMed ID: 17408459
[TBL] [Abstract][Full Text] [Related]
17. Endothelial precursors and mature endothelial cells are increased in the peripheral blood of myelodysplastic syndromes.
Cortelezzi A; Fracchiolla NS; Mazzeo LM; Silvestris I; Pomati M; Somalvico F; Bertolini F; Mancuso P; Pruneri GC; Gianelli U; Pasquini MC; Cortiana M; Deliliers GL
Leuk Lymphoma; 2005 Sep; 46(9):1345-51. PubMed ID: 16109613
[TBL] [Abstract][Full Text] [Related]
18. CD34/QBEND10 immunostaining in bone marrow biopsies: an additional parameter for the diagnosis and classification of myelodysplastic syndromes.
Baur AS; Meugé-Moraw C; Schmidt PM; Parlier V; Jotterand M; Delacrétaz F
Eur J Haematol; 2000 Feb; 64(2):71-9. PubMed ID: 10997326
[TBL] [Abstract][Full Text] [Related]
19. Relation between bone marrow angiogenesis and serum levels of angiogenin in patients with myelodysplastic syndromes.
Alexandrakis MG; Passam FH; Pappa CA; Sfiridaki K; Tsirakis G; Damilakis J; Stathopoulos EN; Kyriakou DS
Leuk Res; 2005 Jan; 29(1):41-6. PubMed ID: 15541473
[TBL] [Abstract][Full Text] [Related]
20. Expression of VEGF and microvessel density in patients with multiple myeloma: clinical and prognostic significance.
Marković O; Marisavljević D; Cemerikić V; Vidović A; Perunicić M; Todorović M; Elezović I; Colović M
Med Oncol; 2008; 25(4):451-7. PubMed ID: 18449811
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]